GMAB
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Genmab is a pharmaceutical company. The company specializes in the research and development of antibodies, which are mainly used in the treatment of cancer patients with lymphatic leukemia and solid tumors. Research and development are based on the company's own developed technology platform and operations are held on a global level. Genmab was founded in 1999 and is headquartered in Copenhagen, Denmark.
Read moreInterim report Q3'26
Revenue B
EBIT-% (adj.)
EPS (adj.)
Dividend %
Don't miss out - create an account and get all the possible benefits